Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.73M Sell
275,144
-67,231
-20% -$1.79M 0.13% 115
2025
Q4
$8.53M Buy
+342,375
New +$8.63M 0.22% 39
2025
Q1
Sell
-61,341
Closed -$1.63M 2929
2024
Q4
$1.63M Buy
61,341
+25,231
+70% +$684K 0.13% 129
2024
Q3
$1.05M Sell
36,110
-37,836
-51% -$1.1M 0.08% 407
2024
Q2
$2.07M Buy
73,946
+49,851
+207% +$1.37M 0.18% 120
2024
Q1
$669K Buy
+24,095
New +$669K 0.09% 326
2023
Q4
Sell
-25,873
Closed -$858K 1990
2023
Q3
$858K Buy
+25,873
New +$915K 0.15% 148
2023
Q1
Sell
-6,987
Closed -$358K 1566
2022
Q4
$358K Sell
6,987
-3,844
-35% -$184K 0.08% 469
2022
Q3
$474K Buy
+10,831
New +$526K 0.12% 262
2022
Q1
Sell
-4,602
Closed -$272K 895
2021
Q4
$272K Sell
4,602
-45,530
-91% -$2.26M 0.15% 238
2021
Q3
$2.16M Buy
+50,132
New +$2.22M 0.72% 9

Other funds holding PFE

XTX Topco's PFE Position: Q1 2026 in Review

XTX Topco reduced its Pfizer (PFE) stake by 20% in Q1 2026, selling an estimated $1.79M and leaving 275,144 shares worth $7.73M. The position accounts for 0.13% of the portfolio, ranked #115.

XTX Topco first reported a position in PFE in Q3 2021 and has held it in 11 quarters since. The position peaked at $8.53M in Q4 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • XTX Topco held 275,144 shares of Pfizer worth $7.73M as of Q1 2026.
  • XTX Topco sold 67,231 Pfizer shares in Q1 2026, an estimated $1.79M.
  • Pfizer made up 0.13% of XTX Topco's portfolio in Q1 2026, its #115 holding.
  • XTX Topco first reported a position in Pfizer in Q3 2021 and has held it in 11 quarters since.
  • XTX Topco's Pfizer position peaked at $8.53M in Q4 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.